ketoconazole has been researched along with palonosetron in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Calcagnile, S; Henriksson, A; Kammerer, KP; Lanzarotti, C; Rossi, G; Timmer, W | 1 |
1 review(s) available for ketoconazole and palonosetron
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for ketoconazole and palonosetron
| Article | Year |
|---|---|
Effect of netupitant, a highly selective NK₁ receptor antagonist, on the pharmacokinetics of palonosetron and impact of the fixed dose combination of netupitant and palonosetron when coadministered with ketoconazole, rifampicin, and oral contraceptives.
Topics: Adolescent; Adult; Antiemetics; Area Under Curve; Contraceptives, Oral; Cross-Over Studies; Drug Interactions; Female; Humans; Isoquinolines; Ketoconazole; Middle Aged; Neurokinin-1 Receptor Antagonists; Palonosetron; Pyridines; Quinuclidines; Randomized Controlled Trials as Topic; Rifampin; Young Adult | 2013 |